# Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency

> **NCT05222152** · PHASE2 · COMPLETED · sponsor: **Neurocrine UK Limited** · enrollment: 58 (actual)

## Conditions studied

- Primary Adrenal Insufficiency

## Interventions

- **DRUG:** Chronocort
- **DRUG:** Plenadren

## Key facts

- **NCT ID:** NCT05222152
- **Lead sponsor:** Neurocrine UK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-23
- **Primary completion:** 2023-10-18
- **Final completion:** 2023-10-18
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05222152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05222152, "Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05222152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*